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The series of articles in this special edition reflect much of the current thinking in regards
to the role of metals in aging and neurodegeneration, and highlight the deep involvement of
metal ions in critical pathways that may contribute to onset/progression of neurological disease.
Furthermore, metal homeostasis may impact directly on signaling cascades relevant to cognition,
or may indirectly contribute to functional decline via an effect on specific pathologies in the
degenerating brain. As such, the behavioral manifestations associated with normal and pathological
aging may be remediated by therapeutics that intervene in metal ion dyshomeostasis.
The broader perspective on the role of metal ions in cognition is outlined in the first two
articles. Opazo et al. (2014) provide an overview of the role of copper in the CNS, and more
specifically review the role of copper on neurotransmission and the ubiquitin proteasome system.
These areas find relevance in the apparent sensitivity of the synapse to the “metal milieu” and
further, to the potential for an involvement in neurodegenerative disorders. Copper is postulated to
regulate the communication between neurons by modifying the protein configuration and strength
of neurotransmission within the CNS. The review by Takeda and Tamano (2014) then provides a
good overview on the now established role of zinc in synaptic plasticity and cognition. They further
explore the impact of the hypothalamic–pituitary–adrenal (HPA) axis on these pathways. In light of
the many avenues by which the HPA axis can be activated, then this represents an interesting area
for further investigation. Similarly, the precise molecular mechanisms underlying the modulation
of zinc signaling across both normal and “pathological” aging remain to be clarified.
The remaining articles are split out according to disease, beginning with ALS. Lovejoy and
Guillemin (2014) provide a thorough and compelling overview on the role of metals in ALS, with a
specific focus on iron and copper. This review provides a great backdrop for the subsequent papers
on ALS, and points toward the potential efficacy of metal-targeting compounds as an avenue for
ALS therapy.
Dang et al. (2014) then specifically examine metal levels in the brain and spinal cord of TDP-
43 mutant mice, and demonstrated a modulation of metals in association with an impairment in
motor function. This is the first report to identify a potential link between TDP-43 and metals, with
further study required to elucidate the mechanisms (which are likely to include oxidative stress)
underlying the observed phenomena.
Bourassa et al. (2014) tackle the metal: ALS interaction from the perspective of the aggregation
of mutant SOD1. After examining cells expressing either WT or mutant SOD1, they discovered
a significant cytoplasmic deficit in copper (which was also found in the aggregates themselves) in
association with all the mutant forms of the protein. Targeting this metal: SOD1 interaction may
thus be a therapeutic approach to limit disease progression. These studies cumulatively add further
evidence to the growing literature on the role of metals in ALS.
The next series of articles have a focus on AD, with discussions around both the mechanistic
and therapeutic implications of altered metal ion homeostasis. McCord and Aizenman (2014)
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provide a thorough review on the role of zinc-dependent
signaling cascades during normal brain aging and in age-related
neurodegeneration, with a particular focus on the production
of reactive oxygen species and subsequent oxidative stress. As
highlighted in the paper, these are phenomena that are applicable
across a broad range of age-related conditions, but which are
particularly relevant to AD where Zn has been extensively
implicated in the pathogenesis of disease.
Wong et al. (2014) explore the links between
metal dyshomeostasis and brain cholesterol in AD,
reviewing potential roles in APP processing, Abeta
generation/aggregaton/degradation and cell toxicity. They
propose a crosstalk between metals and cholesterol in AD
pathogenesis. In a related review, Xu et al. (2014) examine
the interaction between metals and the major genetic risk
factor for AD, ApoE (which is also involved in cholesterol
metabolism). The evidence demonstrates that metals bind to
ApoE in an isoform-specific way, and that ApoE modulates
metal homeostasis in the brain. There is also the possibility that
metals may regulate ApoE levels. These data provide support
for the interaction between ApoE and metals within the brain,
with implications for the pathogenesis of AD. Further exploring
a related notion, Flinn et al. (2014) present a research paper
examining the interaction of dietary zinc in an ADmouse model,
specifically in the context of different ApoE genotypes. The
data demonstrate that zinc supplementation caused significant
impairments in the AD mouse model containing the ApoE E4
allele. These data are very important in the context of human
drug trials and dietary zinc supplementation, as clearly there
are genetic confounds (that themselves may interact with or be
altered by metals) that may impact on the desired effect and/or
disease progressions. This study provides further support for the
growing notion that ApoE genotype is a critical factor in clinical
trial design.
Hancock et al. (2014) then review the evidence supporting
a complex interplay between glia, zinc and synaptic function
across “normal” and “pathological” aging. Brewer then presents
his inorganic copper hypothesis (Brewer, 2014). This postulates
that the ingestion of copper from drinking water and supplement
pills, together with a high fat diet, is a primary mechanism to
account for the increasing prevalence of AD in themodern world.
Furthermore, he notes that zinc deficiency may also be a major
contributor to the development of AD, and goes on to review
some of his own work in this area of zinc supplementation as
a therapeutic avenue in AD (this is a good counter view to
that provided by Flinn and colleagues). The hypotheses around
the role of metals in AD are many and varied, as are their
potential utility as therapeutic targets. This remains an area of
active investigation. The next article by Granzotto and Zatta
(2014) reviews the potential role of resveratrol as a therapeutic
in AD (and potentially normal aging). They focus on how
this natural polyphenol may intervene in AD-related pathways,
including inflammation, mitochondrial dysfunction and more
specifically, those related to oxidative stress and failures in metal
ion homeostasis (zinc, iron, copper, and aluminum).
Finally, Bhattacharjee et al. (2014) provide a review on the
potential role of aluminum in Alzheimer’s disease and go further
by demonstrating (through the use of Gene Chip and miRNA
array techniques) that an aluminum-enriched diet fostered an
upregulation of pro-inflammatory miRNAs in the Tg2576 animal
model of AD.
Finishing this section, Braidy et al. (2014) briefly review
metal-protein interactions in neurodegenerative diseases and
then provide an overview of the various elemental imaging
technologies currently available. They then focus on the
application of these methods in AD. Ultimately, as spatial
resolution and detection sensitivities are improved, we will
be afforded greater insight into the role of metals in disease
development and progression.
The next three articles focus on the role of metals in
other conditions, and utilize a variety of different models.
Sun et al. (2013) examined the apoptotic response across age
following a traumatic brain injury (TBI), and demonstrated a
number of findings. One highlight was a proteomic analysis
that identified an injury-dependent increase in Hsp27. This
protein, amongst other activities, has been shown to decrease
ROS and thus, an endogenous or exogenous increase could
protect against metal-mediated oxidative stress and downstream
consequences. Another protein, the metal (calcium) binding
protein hippocalcin, was also significantly decreased following
injury- and this occurred concomitantly with an increase in
TUNEL-positive cells in the aged animals. The cumulative impact
of apoptosis on neuronal loss post-injury is a likely contributor
to the behavioral deficits that accompany TBI, and metals are
likely to feature in many aspects/signaling cascades of the TBI
brain.
Malakooti et al. (2014) then explore the role of metal
ion homeostasis in the cognitive decline present in Down
syndrome (DS). Given the overlap between AD and DS, there
is good justification to support a metal-mediated aspect to the
pathogenesis of DS. Whilst there are obvious candidates, such as
APP, that support this link (and the subsequent manifestation
of cognitive decline and/or AD), there are many unexplored
candidates that are similarly affected by the trisomy on
chromosome 21 that deserve further attention (including DSCR1
and ITSN1). The data reviewed demonstrate novel pathways
linking DS and metals that may provide novel therapeutic
avenues for the disease.
Finally, Chege and McColl (2014) provide a detailed
description on the use of C. elegans as a model system to
explore the underlying mechanisms of PD. They propose that a
failure in axonal transport is fundamental, with the subsequent
impairment in trafficking of metal ion homeostasis proteins
(focusing on iron) resulting in downstream oxidative stress and
neuronal loss. They also note the potential for the loss of synaptic
connections in this model.
The last manuscript in this special edition is by Marx and
Gilon (2014), and presents a different perspective on memory
than neuroscientists are typically exposed to. They draw together
a discussion around a model that rationalizes the phenomenon
of biologic memory in physical-chemical terms and in doing so,
invoke a potential role for metal ions.
The sum of these articles, which add to my own recent
work in the area, present an overview of the many different
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pathways through whichmetals may intersect in the pathogenesis
of a variety of neurodegenerative diseases, and which may
subsequently manifest (directly or indirectly) in behavioral
deficits.
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